|
WO02100425A1
|
|
Aggregate composition for sustained-release preparation, process for producing the same, and sustained-release preparation containing the same
|
|
JP2003081865A
|
|
Water-insoluble sustained-release composition, its preparation and method for producing the same
|
|
JP2002308798A
|
|
Conjugate composition for sustained release preparation, method for producing the same and sustained release preparation containing the same
|
|
JP2002128694A
|
|
bFGF SUSTAINED RELEASE PREPARATION
|
|
JP2002114667A
|
|
Composition for sustained release preparation, method for producing the same and sustained release microcapsule preparation
|
|
JP2002003398A
|
|
Sustained-release preparation, method for preparing the same, and vaccine therefrom
|
|
JP2001233788A
|
|
Sustained release preparation of insulin and its production method
|
|
JP2001233786A
|
|
Sustained release base material for heparin-binding growth factor and heparin-binding growth factor releasing agent
|
|
JP2001151695A
|
|
Medicine for treating allergic disease
|
|
WO9603500A1
|
|
Sustance with antiviral activity
|
|
JPH0925238A
|
|
Pharmaceutical preparation for pernasal administration
|
|
US5565444A
|
|
Osteogenesis promoter and osteoporosis remedy
|
|
ZA9204669B
|
|
Topical preparations containing cyclosporin.
|
|
IL102236D0
|
|
Topical preparations containing cyclosporin
|
